These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 32886268)
41. Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow? Chou SH; Lo EH; Ning M Crit Care; 2014 Jan; 18(1):101. PubMed ID: 24393331 [TBL] [Abstract][Full Text] [Related]
42. Utility of screening for chronic granulomatous disease in patients with inflammatory bowel disease. Jaggi P; Scherzer R; Knieper R; Mousa H; Prasad V J Clin Immunol; 2012 Feb; 32(1):78-81. PubMed ID: 22089701 [TBL] [Abstract][Full Text] [Related]
43. Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression. Bhopale VM; Ruhela D; Brett KD; Nugent NZ; Fraser NK; Levinson SL; DiNubile MJ; Thom SR J Appl Physiol (1985); 2021 May; 130(5):1604-1613. PubMed ID: 33764168 [TBL] [Abstract][Full Text] [Related]
44. Lupus Erythematosus and Chronic Granulomatous Disease: Report of Four Iranian Patients with AR-CGD and One XL-CGD. Maddah M; Fazlollahi MR; Shiari R; Shahram F; Mamishi S; Babaie D; Monajemzadeh M; Sotudeh S; Hamidieh AA; Badalzadeh M; Tajik S; Sedighipour L; Pourpak Z Iran J Allergy Asthma Immunol; 2019 Aug; 18(4):452-458. PubMed ID: 31522454 [TBL] [Abstract][Full Text] [Related]
45. Serum Biomarkers for Early Diagnosis of Chinese X-CGD Children: Case Reports and a Literature Review. Hou L; Niu WT; Ji HY; Hu XF; Fang F; Ying YQ Curr Med Sci; 2019 Apr; 39(2):343-348. PubMed ID: 31016508 [TBL] [Abstract][Full Text] [Related]
46. Different degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous disease. Carnevale R; Loffredo L; Sanguigni V; Plebani A; Rossi P; Pignata C; Martire B; Finocchi A; Pietrogrande MC; Azzari C; Soresina AR; Martino S; Cirillo E; Martino F; Pignatelli P; Violi F J Am Heart Assoc; 2014 Jun; 3(3):e000920. PubMed ID: 24973227 [TBL] [Abstract][Full Text] [Related]
47. Phenomic Analysis of Chronic Granulomatous Disease Reveals More Severe Integumentary Infections in X-Linked Compared With Autosomal Recessive Chronic Granulomatous Disease. Chiu TL; Leung D; Chan KW; Yeung HM; Wong CY; Mao H; He J; Vignesh P; Liang W; Liew WK; Jiang LP; Chen TX; Chen XY; Tao YB; Xu YB; Yu HH; Terblanche A; Lung DC; Li CR; Chen J; Tian M; Eley B; Yang X; Yang J; Chiang WC; Lee BW; Suri D; Rawat A; Gupta A; Singh S; Wong WHS; Chua GT; Duque JSDR; Cheong KN; Chong PC; Ho MH; Lee TL; Yang W; Lee PP; Lau YL Front Immunol; 2021; 12():803763. PubMed ID: 35140711 [TBL] [Abstract][Full Text] [Related]
49. Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer. Onuma T; Asare-Werehene M; Fujita Y; Yoshida Y; Tsang BK Cells; 2024 May; 13(11):. PubMed ID: 38891037 [TBL] [Abstract][Full Text] [Related]
50. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Dinauer MC; Gifford MA; Pech N; Li LL; Emshwiller P Blood; 2001 Jun; 97(12):3738-45. PubMed ID: 11389011 [TBL] [Abstract][Full Text] [Related]
51. The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance. Manzoor HB; Asare-Werehene M; Pereira SD; Satyamoorthy K; Tsang BK J Ovarian Res; 2024 Jan; 17(1):15. PubMed ID: 38216951 [TBL] [Abstract][Full Text] [Related]
52. Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan. Yanagimachi M; Kato K; Iguchi A; Sasaki K; Kiyotani C; Koh K; Koike T; Sano H; Shigemura T; Muramatsu H; Okada K; Inoue M; Tabuchi K; Nishimura T; Mizukami T; Nunoi H; Imai K; Kobayashi M; Morio T Front Immunol; 2020; 11():1617. PubMed ID: 32849547 [TBL] [Abstract][Full Text] [Related]
53. Mobilization and transduction of CD34(+) peripheral blood stem cells in patients with X-linked chronic granulomatous disease. Ott MG; Merget-Millitzer H; Ottmann OG; Martin H; Brüggenolte N; Bialek H; Seger R; Hossle JP; Hoelzer D; Grez M J Hematother Stem Cell Res; 2002 Aug; 11(4):683-94. PubMed ID: 12201957 [TBL] [Abstract][Full Text] [Related]
54. X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability. Marciano BE; Zerbe CS; Falcone EL; Ding L; DeRavin SS; Daub J; Kreuzburg S; Yockey L; Hunsberger S; Foruraghi L; Barnhart LA; Matharu K; Anderson V; Darnell DN; Frein C; Fink DL; Lau KP; Long Priel DA; Gallin JI; Malech HL; Uzel G; Freeman AF; Kuhns DB; Rosenzweig SD; Holland SM J Allergy Clin Immunol; 2018 Jan; 141(1):365-371. PubMed ID: 28528201 [TBL] [Abstract][Full Text] [Related]
55. Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers. Tsilifis C; Torppa T; Williams EJ; Albert MH; Hauck F; Soncini E; Kang E; Malech H; Schuetz C; von Bernuth H; Slatter MA; Gennery AR J Clin Immunol; 2023 Nov; 43(8):1964-1973. PubMed ID: 37620741 [TBL] [Abstract][Full Text] [Related]
56. Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance. Onuma T; Asare-Werehene M; Yoshida Y; Tsang BK Cells; 2022 Oct; 11(20):. PubMed ID: 36291171 [TBL] [Abstract][Full Text] [Related]
57. The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance. Asare-Werehene M; Nakka K; Reunov A; Chiu CT; Lee WT; Abedini MR; Wang PW; Shieh DB; Dilworth FJ; Carmona E; Le T; Mes-Masson AM; Burger D; Tsang BK Oncogene; 2020 Feb; 39(7):1600-1616. PubMed ID: 31700155 [TBL] [Abstract][Full Text] [Related]
58. The potential role of plasma gelsolin in dialysis-related protein-energy wasting. Lee PS; Bhan I; Thadhani R Blood Purif; 2010; 29(2):99-101. PubMed ID: 20093811 [TBL] [Abstract][Full Text] [Related]
59. The effects of plasma gelsolin on human erythroblast maturation for erythrocyte production. Han SY; Lee EM; Choi HS; Chun BH; Baek EJ Stem Cell Res; 2018 May; 29():64-75. PubMed ID: 29597129 [TBL] [Abstract][Full Text] [Related]